Vatsal Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 24-10-2024
- Paid Up Capital ₹ 2.50 M
as on 24-10-2024
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 24-10-2024
- Revenue 27.65%
(FY 2023)
- Profit 1595.28%
(FY 2023)
- Ebitda -16.12%
(FY 2023)
- Net Worth 6.15%
(FY 2023)
- Total Assets 6.32%
(FY 2023)
About Vatsal Biotech
The Corporate was formerly known as R. Vimal Syncotex Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.00 M.
Varun Saraogi, Mohitkumar Beria, and Tushar Agarwal serve as directors at the Company.
- CIN/LLPIN
U17124RJ1998PTC015097
- Company No.
015097
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Sep 1998
- Date of AGM
03 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationBhilwara, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vatsal Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Saraogi  | Director | 14-Mar-2016 | Current |
| Mohitkumar Beria | Director | 24-Aug-2020 | Current |
| Tushar Agarwal | Director | 14-Mar-2016 | Current |
Financial Performance of Vatsal Biotech.
Vatsal Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.65% increase. The company also saw a substantial improvement in profitability, with a 1595.28% increase in profit. The company's net worth moved up by a moderate rise of 6.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vatsal Biotech?
In 2023, Vatsal Biotech had a promoter holding of 87.59% and a public holding of 12.41%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 30 Mar 2001 | ₹2.00 M | Open |
How Many Employees Work at Vatsal Biotech?
Unlock and access historical data on people associated with Vatsal Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vatsal Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vatsal Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
